News
Background: Despite recent advances, there remains a need for novel therapies for pts with R/R DLBCL. ... This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting II. ... Tucidinostat plus R ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback